These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 16622665

  • 1. F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas.
    Hernandez-Pampaloni M, Takalkar A, Yu JQ, Zhuang H, Alavi A.
    Pediatr Radiol; 2006 Jun; 36(6):524-31. PubMed ID: 16622665
    [Abstract] [Full Text] [Related]

  • 2. Staging in childhood lymphoma: differences between FDG-PET and CT.
    Hermann S, Wormanns D, Pixberg M, Hunold A, Heindel W, Jürgens H, Schober O, Franzius C.
    Nuklearmedizin; 2005 Feb; 44(1):1-7. PubMed ID: 15711722
    [Abstract] [Full Text] [Related]

  • 3. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [Abstract] [Full Text] [Related]

  • 4. Whole-Body Diffusion-Weighted MRI Compared to 18 FFDG PET/CT in Initial Staging and Therapy Response Assessment of Hodgkin Lymphoma in Pediatric Patients.
    Shapira-Zaltsberg G, Wilson N, Trejo Perez E, Abbott L, Dinning S, Kapoor C, Davila J, Smith B, Miller E.
    Can Assoc Radiol J; 2020 May; 71(2):217-225. PubMed ID: 32062992
    [Abstract] [Full Text] [Related]

  • 5. The impact of 18F-FDG PET on initial staging and therapy planning of pediatric soft-tissue sarcoma patients.
    Elmanzalawy A, Vali R, Chavhan GB, Gupta AA, Omarkhail Y, Amirabadi A, Shammas A.
    Pediatr Radiol; 2020 Feb; 50(2):252-260. PubMed ID: 31628508
    [Abstract] [Full Text] [Related]

  • 6. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma.
    Pelosi E, Pregno P, Penna D, Deandreis D, Chiappella A, Limerutti G, Vitolo U, Mancini M, Bisi G, Gallo E.
    Radiol Med; 2008 Jun; 113(4):578-90. PubMed ID: 18414808
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma.
    Ömür Ö, Baran Y, Oral A, Ceylan Y.
    Diagn Interv Radiol; 2014 Jun; 20(2):185-92. PubMed ID: 24412817
    [Abstract] [Full Text] [Related]

  • 9. Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography.
    Hwang K, Park CH, Kim HC, Kim H, Yoon S, Pai M, Kim S.
    Clin Nucl Med; 2000 Oct; 25(10):789-95. PubMed ID: 11043718
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 11. Role of WB-MR/DWIBS compared to (18)F-FDG PET/CT in the therapy response assessment of lymphoma.
    Maggialetti N, Ferrari C, Minoia C, Asabella AN, Ficco M, Loseto G, De Tullio G, de Fazio V, Calabrese A, Guarini A, Rubini G, Brunese L.
    Radiol Med; 2016 Feb; 121(2):132-43. PubMed ID: 26349573
    [Abstract] [Full Text] [Related]

  • 12. Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of hodgkin lymphoma: a single center experience in Brazil.
    Cerci JJ, Pracchia LF, Soares Junior J, Linardi Cda C, Meneghetti JC, Buccheri V.
    Clinics (Sao Paulo); 2009 Feb; 64(6):491-8. PubMed ID: 19578651
    [Abstract] [Full Text] [Related]

  • 13. Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin's lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT.
    Latifoltojar A, Punwani S, Lopes A, Humphries PD, Klusmann M, Menezes LJ, Daw S, Shankar A, Neriman D, Fitzke H, Clifton-Hadley L, Smith P, Taylor SA.
    Eur Radiol; 2019 Jan; 29(1):202-212. PubMed ID: 29948084
    [Abstract] [Full Text] [Related]

  • 14. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG, Taverna C, Strobel K, Wastl C, Kurrer M, Hany TF.
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [Abstract] [Full Text] [Related]

  • 15. The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.
    Bhojwani D, McCarville MB, Choi JK, Sawyer J, Metzger ML, Inaba H, Davidoff AM, Gold R, Shulkin BL, Sandlund JT.
    Br J Haematol; 2015 Mar; 168(6):845-53. PubMed ID: 25382494
    [Abstract] [Full Text] [Related]

  • 16. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma.
    Rhodes MM, Delbeke D, Whitlock JA, Martin W, Kuttesch JF, Frangoul HA, Shankar S.
    J Pediatr Hematol Oncol; 2006 May; 28(5):300-6. PubMed ID: 16772881
    [Abstract] [Full Text] [Related]

  • 17. 18F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with 18F-FDG PET/CT as the Reference Standard.
    Verhagen MV, Menezes LJ, Neriman D, Watson TA, Punwani S, Taylor SA, Shankar A, Daw S, Humphries PD.
    J Nucl Med; 2021 Nov; 62(11):1524-1530. PubMed ID: 33608429
    [Abstract] [Full Text] [Related]

  • 18. Whole-body 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET/CT) for staging locally advanced breast cancer: A prospective study from a tertiary cancer centre in south India.
    Gajjala SR, Hulikal N, Kadiyala S, Kottu R, Kalawat T.
    Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
    [Abstract] [Full Text] [Related]

  • 19. Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma.
    Cheng G, Servaes S, Zhuang H.
    Leuk Lymphoma; 2013 Apr; 54(4):737-42. PubMed ID: 22957898
    [Abstract] [Full Text] [Related]

  • 20. (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging.
    Lopci E, Burnelli R, Ambrosini V, Nanni C, Castellucci P, Biassoni L, Rubello D, Fanti S.
    Cancer Biother Radiopharm; 2008 Dec; 23(6):681-90. PubMed ID: 19111053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.